Is topical minoxidil safe for a patient with glaucoma, and should oral minoxidil be avoided?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Minoxidil Use in Glaucoma Patients

Both topical and oral minoxidil can be safely used by patients with glaucoma, as minoxidil does not affect intraocular pressure or worsen glaucoma.

Topical Minoxidil Safety

  • Topical minoxidil has no contraindications in glaucoma patients and does not impact intraocular pressure, making it safe for both open-angle and narrow-angle glaucoma 1.

  • The primary concerns with topical minoxidil are dermatologic (scalp irritation, contact dermatitis) rather than ophthalmologic 2, 3.

  • While one case report suggested a possible association between topical 5% minoxidil and non-arteritic anterior ischemic optic neuropathy, this resolved after discontinuation and represents an extremely rare occurrence 4. This should not preclude use in glaucoma patients, as the mechanism is unrelated to intraocular pressure or glaucoma progression.

Oral Minoxidil Safety

  • Low-dose oral minoxidil (LDOM) is also safe for glaucoma patients, as it does not affect intraocular pressure 1.

  • In a large multicenter study of 1,404 patients taking LDOM, systemic adverse effects were infrequent (lightheadedness 1.7%, fluid retention 1.3%, tachycardia 0.9%), with only 1.7% discontinuing treatment due to side effects 5. Notably, no ophthalmologic complications or glaucoma-related issues were reported.

  • The cardiovascular effects of LDOM (used at doses below those that lower blood pressure) are minimal and unrelated to glaucoma management 2, 5.

Important Clinical Considerations

  • Patients should avoid scalp occlusion (tight caps, wigs immediately after application) when using topical minoxidil, as this increases systemic absorption and risk of hypertrichosis 6.

  • Hypertrichosis (unwanted hair growth) is the most common adverse effect of both formulations, occurring in approximately 15% of patients on oral minoxidil, though it rarely leads to discontinuation 5.

  • No special monitoring of intraocular pressure is required specifically for minoxidil use, though glaucoma patients should continue their routine ophthalmologic follow-up as recommended for their condition 7.

Contrast with Medications That Require Caution

Unlike certain medications that do require caution in glaucoma (such as anticholinergics in narrow-angle glaucoma, or corticosteroids which can elevate intraocular pressure), minoxidil poses no such risk 8. This makes it a straightforward choice for hair loss treatment in glaucoma patients without need for additional ophthalmologic consultation or monitoring beyond standard glaucoma care.

References

Guideline

Pregabalin Use in Open-Angle Glaucoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Oral minoxidil treatment for hair loss: A review of efficacy and safety.

Journal of the American Academy of Dermatology, 2021

Research

Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy?

Journal of clinical and diagnostic research : JCDR, 2016

Research

Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.

Journal of the American Academy of Dermatology, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medications to Avoid in Glaucoma Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.